Study of the Willebrand factor in patients with venous thrombosis
Tsiguleva, O.A.
Laboratornoe Delo 2: 7-9
1988
ISSN/ISBN: 0023-6748 PMID: 2452298 Document Number: 317888
Document emailed within 1 workday
Related Documents
Nichols, T.C.; Bellinger, D.A.; Reddick, R.L.; Read, M.S.; Koch, G.G.; Brinkhous, K.M.; Griggs, T.R. 1991: Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs Circulation 83(6): Iv56-Iv64Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Lu, G-yuan.; Shen, L.; Wang, Z-yue.; Guo, X-fang.; Bai, X.; Su, J.; Ruan, C-geng. 2008: Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases Chinese Medical Journal 121(2): 133-136
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Sharma, S.K.; Gupta, V.; Kadhiravan, T.; Banga, A.; Seith, A.; Kumar, A.; Saxena, R.; Thabah, M.M.; Gulati, V.; Bhatia, I.; Kavimandan, A.A. 2009: A prospective study of risk factor profile and incidence of deep venous thrombosis among medically-ill hospitalized patients at a tertiary care hospital in northern India Indian Journal of Medical Research 130(6): 726-730
Perutelli, P.; Mori, P.G. 1997: Interaction of the von Willebrand factor with platelets and thrombosis Recenti Progressi in Medicina 88(11): 526-529
Prountjos, P.; Bastounis, E.; Hadjinikolaou, L.; Felekuras, E.; Balas, P. 1991: Superficial venous thrombosis of the lower extremities co-existing with deep venous thrombosis. a phlebographic study on 57 cases International Angiology: a Journal of the International Union of Angiology 10(2): 63-65
Goto, S. 2001: Role of von Willebrand Factor for the Onset of Arterial Thrombosis Clinical Laboratory 47(7-8): 327-334
Koopman, K.; Uyttenboogaart, M.; Vroomen, P.C.A.J.; van der Meer, J.; De Keyser, J.; Luijckx, G-Jan. 2009: Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years Thrombosis and haemostasis 102(4): 620-622
O'Brien, J.R.; Etherington, M.D. 1997: The endothelial von Willebrand factor in venous occlusion blood Thrombosis and Haemostasis 78(6): 1528-1529
González-Gay, M.A.; Alvarez, M.D.; Machín, A.J.; Alonso, M.D.; García González, J.; Cereijo, M.J.; Bal, M. 1992: Comparative study of von Willebrand factor in patients with temporal arteritis Anales de Medicina Interna 9(10): 483-486
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Girma, J.P.; Pietu, G.; Lavergne, J.M.; Meyer, D.; Larrieu, M.J. 1982: Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease Journal of Laboratory and Clinical Medicine 99(4): 481-494
Sultan, Y.; Simeon, J.; Caen, J.P. 1976: Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease Journal of Laboratory and Clinical Medicine 87(2): 185-194
Martinelli, I.; Landi, G.; Merati, G.; Cella, R.; Tosetto, A.; Mannucci, P.M. 1996: Factor V gene mutation is a risk factor for cerebral venous thrombosis Thrombosis and Haemostasis 75(3): 393-394
Meyer, D.; Obert, B.; Pietu, G.; Lavergne, J.M.; Zimmerman, T.S. 1980: Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease Journal of Laboratory and Clinical Medicine 95(4): 590-602
Olafsson, I.; Hjaltadóttir, S.; Onundarson, P.T.; Pórarinsdóttir, R.; Haraldsdóttir, V. 1998: Prevalence of factor V(Q506) and prothrombin 20210 a mutations in an apparently healthy Icelandic population and patients suffering from venous thrombosis Thrombosis and Haemostasis 79(3): 685-686
Dahlbäck, B. 1997: Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis Thrombosis and Haemostasis 78(1): 483-488
Canales Albendea, M.A.; Villar Camacho, A.; Chamarro Merino, G.; Magallón Martínez, M. 1998: Ultrapure factor VIIi concentrate with double virus inactivation: study of pharmacokinetics in von Willebrand's disease patients Sangre 43(1): 93-94
Bai, C.; Pan, J.; Fan, L. 2000: A study on the deficiency of anticoagulant proteins in Chinese patients with deep venous thrombosis Zhonghua Nei Ke Za Zhi 39(11): 746-748